Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Specific Biologics logo — DEVELOPING NEXT GENERATION GENE EDITING TECHNOLOGIES

Specific Biologics

DEVELOPING NEXT GENERATION GENE EDITING TECHNOLOGIES

Founded 2017 Canada Toronto, Canada 17 employees Seed Biotechnology

General Information

Company Name Specific Biologics
Founded Year 2017
Location Canada Toronto, Canada
Employees 17
Industries Biotechnology
Funding Stage Seed
Business Model Platform, B2B
Revenue Model Licensing, Product Sales, Performance Based
Social

BounceWatch is an independent company data service, not affiliated with Specific Biologics. To contact Specific Biologics, visit specificbiologics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Specific Biologics compare?

A PDF of Specific Biologics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Specific Biologics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Specific Biologics

Specific Biologics, founded in 2017, is a promising player in the Biotechnology industry, headquartered in Canada. This innovative company focuses on developing the next generation of gene editing technologies, as highlighted by their slogan: "DEVELOPING NEXT GENERATION GENE EDITING TECHNOLOGIES".

Their mission is centered around novel gene editing solutions aimed at treating genetic diseases within the body's cells. The core of their research is a platform technology utilizing a dual-cleaving nuclease, promising safer delivery and effective repair harnessing the cell’s natural DNA repair mechanisms.

Recently, Specific Biologics secured a Seed Round investment on 10 October 2023, with notable contributions from adMare BioInnovations and Lumira Ventures. This financial backing marks a critical vote of confidence in their technological advancements and potential impact in biotechnology.

Business keywords: Gene Editing, DNA Repair, Genetic Disease Treatment, Dual-Cleaving Nuclease, Cellular Delivery, Platform Technology, In Vivo Gene Editing, Novel Therapies, Biological Engineering, Precision Medicine, Molecular Biotechnology

Services & Products

Development of Dualase genome editing platform
Creation of in vivo therapeutics
Precise genetic corrections for medical conditions

Target Customers

Biotechnology researchers Medical professionals focused on genetic disorders Healthcare institutions involved in therapeutic innovations Patients with genetic disorders such as Repeat Expansion

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 2
adMare BioInnovations Lumira Ventures
adMare BioInnovations, Lumira Ventures
10 Oct 2023
Seed Round Undisclosed 2
adMare BioInnovations Lumira Ventures
adMare BioInnovations, Lumira Ventures
16 Dec 2021
Non Equity Assistance Undisclosed 1
Creative Destruction Lab
Creative Destruction Lab
03 Jun 2020

Specific Biologics Alternatives & Competitors

View All Alternatives
Specific Biologics vs
Acrigen Biosciences
Acrigen Biosciences United States

Developing life-saving genetic therapies using our proprietary precision gene editing technology

Seed
6 employees
Biotechnology, Life Sciences
Specific Biologics vs
Full Circles Therapeutics Inc.
Full Circles Therapeutics Inc. United States

Genome Engineering Comes Full Circle. Harnessing revolutionary, virus-free, technology for DNA read...

Venture round
4 employees
Biotechnology, Health Care
Specific Biologics vs
Graphite Bio
Graphite Bio United States

Creating a future where the word 'incurable' no longer exists.

Acquired
2 employees
Biotechnology
View all alternatives

FAQ About Specific Biologics

DEVELOPING NEXT GENERATION GENE EDITING TECHNOLOGIES
Specific Biologics was founded in 2017.
Specific Biologics is headquartered in Toronto, Canada.
Specific Biologics operates in Biotechnology. Its work centres on Gene Editing, DNA Repair, Genetic Disease Treatment and Dual-Cleaving Nuclease. Its customers include Biotechnology researchers, Medical professionals focused on genetic disorders and Healthcare institutions involved in therapeutic innovations.
Specific Biologics has a Platform and B2B business model. Its revenue comes from Licensing, Product Sales and Performance Based.
Specific Biologics has approximately 17 employees.
Specific Biologics has completed 3 funding rounds. The latest funding stage is Seed.
Specific Biologics offers: Development of Dualase genome editing platform, Creation of in vivo therapeutics, Precise genetic corrections for medical conditions.
Top alternatives and competitors to Specific Biologics include Acrigen Biosciences, Full Circles Therapeutics Inc., Graphite Bio, Scribe Therapeutics, SonoThera. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Specific Biologics and Acrigen Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Specific Biologics, https://bouncewatch.com/company/specific-biologics, updated 6 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout